Epididymo-orchitis
Epididymo-orchitis is acute inflammation of the epididymis with or without testicular involvement, usually from ascending sexually transmitted or urinary pathogens; the first decision is whether the acute scrotum could be testicular torsion, because imaging and antibiotics must never delay urgent exploration.
In a nutshell
Epididymo-orchitis is acute scrotal inflammation usually caused by ascending sexually transmitted or urinary pathogens. The critical first step is to exclude testicular torsion, because Doppler ultrasound must not delay exploration. Test for chlamydia, gonorrhoea and urinary pathogens, treat empirically according to risk and current safety guidance, give analgesia and scrotal support, manage partners when an STI is confirmed, and review early if symptoms worsen or fail to improve.
Classic presentation
An adult has unilateral scrotal pain and swelling with a tender epididymis, dysuria or urethral discharge and a several-hour-to-day course; the clinician actively assesses torsion before starting antibiotics.
Key points
- Sexually transmitted pathogens are more likely with recent sexual exposure, while enteric pathogens are more likely with urinary symptoms, instrumentation, catheterisation, urinary-tract abnormality or insertive anal intercourse; age is only a guide.
- Sudden severe pain, nausea, abnormal testicular lie or an absent cremasteric reflex raises concern for torsion, but no bedside sign reliably excludes it.
- If torsion is clinically possible, urgent exploration takes priority over ultrasound, urine tests and antibiotics.
- For probable sexually acquired disease, use current gonorrhoea-inclusive treatment plus an appropriate chlamydia course, checked against current BNF and local policy.
- Enteric pathways may include a fluoroquinolone in BASHH guidance, but MHRA now restricts systemic fluoroquinolones to situations where other recommended antibiotics are inappropriate.
- Mumps orchitis is viral and supportive; persistent or uropathogen-confirmed disease needs reassessment and often urology evaluation.
First-line investigation
Immediate torsion-focused examination plus first-pass urine or urethral NAAT for chlamydia and gonorrhoea, urine dipstick/culture and Doppler ultrasound only when uncertainty or complications justify it without delaying surgery.
Management
Treat the acute scrotum as torsion until safely excluded
- Any clinically possible torsion requires immediate urological exploration; do not let ultrasound, NAAT or antibiotics delay the decision.1
Test and start empirical treatment
Relieve pain and manage sexual-health risk
Separate viral, atypical and resistant pathways
Exam traps
- Do not let a positive urine test or a reassuring bedside sign distract from possible torsion; urgent exploration takes priority.
- Doppler ultrasound can be false-negative and must not delay surgery when torsion is clinically suspected.
- Doxycycline alone does not cover gonorrhoea; use the current gonorrhoea-inclusive regimen when indicated.
- Do not prescribe a fluoroquinolone casually: MHRA restricts systemic use to situations where other recommended antibiotics are inappropriate.
- A confirmed urinary pathogen in an adult warrants assessment for urinary-tract obstruction or structural abnormality.
- Mumps orchitis is viral, and bilateral disease can impair fertility; antibiotics do not treat it.
Illustrations
Key sources
- BASHH, UK national guideline for the management of epididymo-orchitis (Current BASHH guideline covering torsion exploration, diagnostic testing, empirical treatment, partner care and urology follow-up; updated 2020 and listed in the current BASHH guideline library)Published 11 Sept 2020
- BASHH, National guideline for the management of infection with Neisseria gonorrhoeae (Current UK gonorrhoea guideline retaining ceftriaxone 1 g for gonococcal epididymo-orchitis; version dated 1 April 2025)Published 1 Apr 2025
- UKHSA, Mumps: the Green Book chapter (Current UK mumps immunisation and public-health guidance, updated April 2026)Published 20 Mar 2013
- UKHSA, Notifiable diseases and how to report them (Current England notification guidance listing mumps as a routine notifiable disease; updated May 2026)Published 12 Sept 2024
- BNF, antibacterial drugs and sexual-health prescribing (Current UK prescribing cross-check for ceftriaxone, doxycycline, fluoroquinolones, moxifloxacin, renal dosing, interactions, pregnancy and safety cautions)
- MHRA, Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate (Current UK safety restriction on systemic fluoroquinolone prescribing and counselling; published January 2024)Published 22 Jan 2024
- BASHH, Guideline for the management of infection with Mycoplasma genitalium (Current BASHH guidance stating that routine M. genitalium testing is not recommended for epididymo-orchitis without specific indications; published November 2024)Published 21 Nov 2024
- BASHH, Epididymo-orchitis patient information (Current patient-facing follow-up and safety-net information, including review if worsening or not improving within 3 days; revision date January 2027)Published 1 Oct 2022
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

